Is Takeda Pharmaceutical Company Limited (TAK) a Buy, Sell, or Hold?
Takeda Pharmaceutical Company Limited
NYSE:TAK
$16.39 USD
-$0.1 (-0.61%)
- Volume
- 5.06M
- Average Volume
- 2.95M
- Market Capitalization
- $52.14B
- P/E Ratio
- 43.35
- Dividend Yield
- 3.78%
- Price Target
- $
- Year High
- $18.90
- Year Low
- $12.99
- Day High
- —
- Day Low
- —
- Payout Ratio
- $1.63
- Current Ratio
- $1.27
CCURRENT INSTITUTIONAL OWNERSHIP PERCENTAGE
0.02%
Investors Holding
22
change: -343 | last: 365
Increased Positions
7
change: -222 | last: 229
Reduced Positions
6
change: -55 | last: 61
New Positions
4
change: -53 | last: 57
Sold Positions
342
change: 297 | last: 45
Total Calls
-
Total Puts
-
Put-Call Ratio
0.00
change: -4.49 | last: 0.0449
Total Invested
10.43M
TAK Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2939.33 | 3.15B | $9.26T | $597.63B | $4.9T | $13.56T |
| 2025-03-31 | $2229.76 | 3.21B | $7.16T | $385.11B | $4.52T | $11.29T |
| 2024-03-31 | $2072.95 | 3.13B | $6.49T | $457.8B | $4.84T | $10.87T |
| 2023-03-31 | $2187.36 | 3.1B | $6.79T | $533.53B | $4.38T | $10.64T |
| 2022-03-31 | $1742.07 | 3.13B | $5.45T | $849.7B | $4.35T | $8.94T |
| 2021-03-31 | $2020.91 | 3.12B | $6.31T | $966.22B | $4.64T | $9.98T |
| 2020-03-31 | $1631.76 | 3.11B | $5.08T | $637.61B | $5.09T | $9.54T |
| 2019-03-31 | $2281.42 | 1.92B | $4.39T | $702.09B | $5.75T | $9.44T |
| 2018-03-31 | $2593.81 | 1.56B | $4.05T | $294.52B | $985.66B | $4.74T |
| 2017-03-31 | $2632.62 | 1.56B | $4.11T | $319.46B | $1.14T | $4.94T |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2939.33 | 3.12B | $9.19T | $597.63B | $4.9T | $13.49T |
| 2025-12-31 | $2445.32 | 3.16B | $7.73T | $655.38B | $4.86T | $11.93T |
| 2025-09-30 | $2163.84 | 3.15B | $6.83T | $681.49B | $4.65T | $10.79T |
| 2025-06-30 | $2225.85 | 3.13B | $6.97T | $350.01B | $4.51T | $11.12T |
| 2025-03-31 | $2229.76 | 3.16B | $7.05T | $385.11B | $4.52T | $11.18T |
| 2024-12-31 | $2082.81 | 3.17B | $6.6T | $494.13B | $4.84T | $10.95T |
| 2024-09-30 | $2042.32 | 3.17B | $6.47T | $859.02B | $5.05T | $10.66T |
| 2024-06-30 | $2093.56 | 3.14B | $6.57T | $804.27B | $5.48T | $11.25T |
| 2024-03-31 | $2072.95 | 3.14B | $6.5T | $457.8B | $4.84T | $10.89T |
| 2023-12-31 | $2011.39 | 3.14B | $6.31T | $288.36B | $4.66T | $10.69T |
| 2023-09-30 | $2310.01 | 3.13B | $7.23T | $318.05B | $4.68T | $11.59T |
| 2023-06-30 | $2266.64 | 3.11B | $7.05T | $316.38B | $4.75T | $11.48T |